The Indian Pharmaceutical Market Outlook To 2014: Market trends, key players, forecast

The Indian Pharmaceutical Market Outlook To 2014: Market trends, key players, forecast

The Indian pharmaceutical market is set for rapid growth over the next decade. This expansion will be driven by an ageing population and a gradual shift in disease burden from anti-infectives and gastrointestinal disorders to cardiovascular, central nervous system and other chronic diseases. However, despite an extensive healthcare system, India’s performance on health indicators remains low, and this has led to an increase in private healthcare services and public/private partnerships. ‘The Indian Pharmaceutical Market Outlook to 2014′ is a new report published by Business Insights that provides comprehensive coverage of the Indian pharma market, with analysis of the healthcare system, pricing and regulation, and a detailed examination of leading companies and potential healthcare reforms. It assesses the marketed product portfolios, R&D pipelines, market share data, sales forecasts and competitive landscape of the major players in the Indian pharma market. Recent events and R&D trends that are likely to influence treatment sales are identified and the competitive dynamics of leading brands within each indication are analyzed. This report also highlights growth trends and developments for key drug classes and leading players through to 2014.

Key Chapters :

The Indian Pharmaceutical Market Outlook to 2014
Executive summary 10
Overview of India 10
The Indian healthcare system 11
The pharmaceutical industry in India 12
Key players in the Indian pharmaceutical market 13
Indian pharmaceutical market SWOT analysis 14
Chapter 1 Scope and methodology 16
Scope 16
Methodology 16
Scope of IMS data 17
Chapter 2 Overview of India 20
Summary 20
Introduction 21
Overview of Indian history 21
The government 21
A burgeoning economy 22
Key economic parameters 23
An imprint of the global slowdown 24
Population profile and demographic trends 26
Disease burden 27
Vector-borne diseases 31
Chapter 3 The Indian healthcare system 34
Summary 34
Introduction 35
Healthcare system 37
The rural healthcare system 38
The urban healthcare system 39
Specialist and emergency medical care 40
The regulatory set-up 41
Intellectual property rights 41
Effect of IPR regime on innovation 42
Financing healthcare 43
Inefficiencies fueled by underutilization of funds 45
Pricing and reimbursement 46
Private health insurance 47
Private healthcare 49
A range of private healthcare services 50
Public-private partnerships 50
Alternative medicine: AYUSH 51
Ayurveda 51
Yoga 52
Naturopathy 52
Unani 52
Siddha 53
Homoeopathy 53
Chapter 4 The pharmaceutical market in
India 56
Summary 56
Introduction 57
Key market trends, events and issues 59
Therapy area analysis 64
Therapy area sales forecast 74
Leading brands 75
Leading brands sales forecast 79
Over-the-counter medication 80
The Indian generics advantage 80
Chapter 5 Key players in the Indian
pharmaceutical market 84
Summary 84
Introduction 85
Leading players of the Indian pharmaceutical market 86
Detailed analysis of the Indian pharmaceutical market players 87
Cipla 87
Overview 87
Sales focus by leading drug classes 88
Sales focus by leading brands 91
New product launches 92
SWOT analysis 94
Strengths 94
Weaknesses 95
Opportunities 96
Threats 96
Ranbaxy 97
Overview 97
Sales focus by leading drug classes 97
Sales focus by leading brands 99
R&D pipeline analysis 101
SWOT analysis 103
Strengths 103
Weaknesses 104
Opportunities 105
Threats 106
GlaxoSmithKline (India) 106
Overview 106
Sales focus by leading drug classes 107
Sales focus by leading brands 108
R&D pipeline analysis 111
SWOT analysis 112
Strengths 112
Weaknesses 113
Opportunities 113
Threats 115
Piramal Healthcare 115
Overview 115
Sales focus by leading drug classes 115
Sales focus by leading brands 117
R&D pipeline analysis 119
SWOT analysis 120
Strengths 120
Weaknesses 122
Opportunities 122
Threats 123
Zydus Cadila 123
Overview 123
Sales focus by leading drug classes 124
Sales focus by leading brands 125
R&D pipeline analysis 126
SWOT analysis 127
Strengths 127
Weaknesses 128
Opportunities 128
Threats 129
A snapshot of other key market players 129
Sun Pharma 129
Lupin 130
Alkem 131
Sanofi-Aventis 132
Mankind Pharma 133
Leading players in the Indian pharmaceutical market: sales forecast 134
Chapter 6 Appendix 136
IMS data 136
Anatomical Therapeutic Classification (ATC) 136
A: Alimentary tract and metabolism 136
B: Blood and blood-forming organs 136
C: Cardiovascular system 136
D: Dermatologicals 137
G: Genito-urinary system and sex hormones 137
H: Systemic hormonal preparations 137
J: General anti-infectives systemic 137
L: Antineoplastic and immunomodulating agents 137
M: Musculo-skeletal system 137
N: Nervous system 138
R: Respiratory system 138
S: Sensory organs 138
T: Diagnostic agents 138
V: Various 138
Glossary 139
Index 141

To know more and to buy a copy of your report feel free to visit :

http://www.bharatbook.com/detail.asp?id=111496&rt=The-Indian-Pharmaceutical-Market-Outlook-To-2014-Market-trends-key-players-forecast.html

Or

Contact us at :

Bharat Book Bureau
Tel: +91 22 27578668
Fax: +91 22 27579131
Email: info@bharatbook.com
Website: www.bharatbook.com
Follow us on twitter: http://twitter.com/3bbharatbook

Gill asks players to make optimum use of available facilities to deliver the best
Union Sports Minister M S Gill on Sunday appealed to Indian players, participating in the upcoming Commonwealth Games, to fully utilise the infrastructure facilities given to them by the government and deliver their best.

Read more on Calcutta News

Ubisoft getting videogame players off the couch
Ubisoft is tapping into camera and motion-sensing technologies to pump out videogames that get players up and moving, sometimes even away from television screens.

Read more on AFP via Yahoo! News

“Boundaries are man made. Players shouldn’t be divided over nationalities,” says Aamir Khan speaking on the IPL controversy.

Watch Live Sports Channels and Sports Events only @ – www.livesportsonweb.com